Flavivirus RNA methylation

Hongping Dong, Katja Fink, Roland Züst, Siew Pheng Lim, Cheng Feng Qin, Pei-Yong Shi

Research output: Contribution to journalReview article

49 Citations (Scopus)

Abstract

The 5′ end of eukaryotic mRNA contains the type-1 (m7GpppNm) or type-2 (m7GpppNmNm) cap structure. Many viruses have evolved various mechanisms to develop their own capping enzymes (e.g. flavivirus and coronavirus) or to 'steal' caps from host mRNAs (e.g. influenza virus). Other viruses have developed 'cap-mimicking' mechanisms by attaching a peptide to the 5′ end of viral RNA (e.g. picornavirus and calicivirus) or by having a complex 5′ RNA structure (internal ribosome entry site) for translation initiation (e.g. picornavirus, pestivirus and hepacivirus). Here we review the diverse viral RNA capping mechanisms. Using flavivirus as a model, we summarize how a single methyltransferase catalyses two distinct N-7 and 2′-O methylations of viral RNA cap in a sequential manner. For antiviral development, a structural feature unique to the flavivirus methyltransferase was successfully used to design selective inhibitors that block viral methyltransferase without affecting host methyltransferases. Functionally, capping is essential for prevention of triphosphate-triggered innate immune activation; N-7 methylation is critical for enhancement of viral translation; and 2′-O methylation is important for subversion of innate immune response during viral infection. Flaviviruses defective in 2′-O methyltransferase are replicative, but their viral RNAs lack 2′-O methylation and are recognized and eliminated by the host immune response. Such mutant viruses could be rationally designed as live attenuated vaccines. This concept has recently been proved with Japanese encephalitis virus and dengue virus. The findings obtained with flavivirus should be applicable to other RNA viruses.

Original languageEnglish (US)
Pages (from-to)763-778
Number of pages16
JournalJournal of General Virology
Volume95
Issue numberPART 4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Flavivirus
Methylation
Viral RNA
Methyltransferases
RNA
Picornaviridae
Viruses
Japanese Encephalitis Virus
RNA Caps
Pestivirus
Attenuated Vaccines
Messenger RNA
Coronavirus
Dengue Virus
RNA Viruses
Virus Diseases
Orthomyxoviridae
Innate Immunity
Hepacivirus
Antiviral Agents

ASJC Scopus subject areas

  • Virology

Cite this

Dong, H., Fink, K., Züst, R., Lim, S. P., Qin, C. F., & Shi, P-Y. (2014). Flavivirus RNA methylation. Journal of General Virology, 95(PART 4), 763-778. https://doi.org/10.1099/vir.0.062208-0

Flavivirus RNA methylation. / Dong, Hongping; Fink, Katja; Züst, Roland; Lim, Siew Pheng; Qin, Cheng Feng; Shi, Pei-Yong.

In: Journal of General Virology, Vol. 95, No. PART 4, 2014, p. 763-778.

Research output: Contribution to journalReview article

Dong, H, Fink, K, Züst, R, Lim, SP, Qin, CF & Shi, P-Y 2014, 'Flavivirus RNA methylation', Journal of General Virology, vol. 95, no. PART 4, pp. 763-778. https://doi.org/10.1099/vir.0.062208-0
Dong H, Fink K, Züst R, Lim SP, Qin CF, Shi P-Y. Flavivirus RNA methylation. Journal of General Virology. 2014;95(PART 4):763-778. https://doi.org/10.1099/vir.0.062208-0
Dong, Hongping ; Fink, Katja ; Züst, Roland ; Lim, Siew Pheng ; Qin, Cheng Feng ; Shi, Pei-Yong. / Flavivirus RNA methylation. In: Journal of General Virology. 2014 ; Vol. 95, No. PART 4. pp. 763-778.
@article{6fe26091ab984a6da1cd1230ee022985,
title = "Flavivirus RNA methylation",
abstract = "The 5′ end of eukaryotic mRNA contains the type-1 (m7GpppNm) or type-2 (m7GpppNmNm) cap structure. Many viruses have evolved various mechanisms to develop their own capping enzymes (e.g. flavivirus and coronavirus) or to 'steal' caps from host mRNAs (e.g. influenza virus). Other viruses have developed 'cap-mimicking' mechanisms by attaching a peptide to the 5′ end of viral RNA (e.g. picornavirus and calicivirus) or by having a complex 5′ RNA structure (internal ribosome entry site) for translation initiation (e.g. picornavirus, pestivirus and hepacivirus). Here we review the diverse viral RNA capping mechanisms. Using flavivirus as a model, we summarize how a single methyltransferase catalyses two distinct N-7 and 2′-O methylations of viral RNA cap in a sequential manner. For antiviral development, a structural feature unique to the flavivirus methyltransferase was successfully used to design selective inhibitors that block viral methyltransferase without affecting host methyltransferases. Functionally, capping is essential for prevention of triphosphate-triggered innate immune activation; N-7 methylation is critical for enhancement of viral translation; and 2′-O methylation is important for subversion of innate immune response during viral infection. Flaviviruses defective in 2′-O methyltransferase are replicative, but their viral RNAs lack 2′-O methylation and are recognized and eliminated by the host immune response. Such mutant viruses could be rationally designed as live attenuated vaccines. This concept has recently been proved with Japanese encephalitis virus and dengue virus. The findings obtained with flavivirus should be applicable to other RNA viruses.",
author = "Hongping Dong and Katja Fink and Roland Z{\"u}st and Lim, {Siew Pheng} and Qin, {Cheng Feng} and Pei-Yong Shi",
year = "2014",
doi = "10.1099/vir.0.062208-0",
language = "English (US)",
volume = "95",
pages = "763--778",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",
number = "PART 4",

}

TY - JOUR

T1 - Flavivirus RNA methylation

AU - Dong, Hongping

AU - Fink, Katja

AU - Züst, Roland

AU - Lim, Siew Pheng

AU - Qin, Cheng Feng

AU - Shi, Pei-Yong

PY - 2014

Y1 - 2014

N2 - The 5′ end of eukaryotic mRNA contains the type-1 (m7GpppNm) or type-2 (m7GpppNmNm) cap structure. Many viruses have evolved various mechanisms to develop their own capping enzymes (e.g. flavivirus and coronavirus) or to 'steal' caps from host mRNAs (e.g. influenza virus). Other viruses have developed 'cap-mimicking' mechanisms by attaching a peptide to the 5′ end of viral RNA (e.g. picornavirus and calicivirus) or by having a complex 5′ RNA structure (internal ribosome entry site) for translation initiation (e.g. picornavirus, pestivirus and hepacivirus). Here we review the diverse viral RNA capping mechanisms. Using flavivirus as a model, we summarize how a single methyltransferase catalyses two distinct N-7 and 2′-O methylations of viral RNA cap in a sequential manner. For antiviral development, a structural feature unique to the flavivirus methyltransferase was successfully used to design selective inhibitors that block viral methyltransferase without affecting host methyltransferases. Functionally, capping is essential for prevention of triphosphate-triggered innate immune activation; N-7 methylation is critical for enhancement of viral translation; and 2′-O methylation is important for subversion of innate immune response during viral infection. Flaviviruses defective in 2′-O methyltransferase are replicative, but their viral RNAs lack 2′-O methylation and are recognized and eliminated by the host immune response. Such mutant viruses could be rationally designed as live attenuated vaccines. This concept has recently been proved with Japanese encephalitis virus and dengue virus. The findings obtained with flavivirus should be applicable to other RNA viruses.

AB - The 5′ end of eukaryotic mRNA contains the type-1 (m7GpppNm) or type-2 (m7GpppNmNm) cap structure. Many viruses have evolved various mechanisms to develop their own capping enzymes (e.g. flavivirus and coronavirus) or to 'steal' caps from host mRNAs (e.g. influenza virus). Other viruses have developed 'cap-mimicking' mechanisms by attaching a peptide to the 5′ end of viral RNA (e.g. picornavirus and calicivirus) or by having a complex 5′ RNA structure (internal ribosome entry site) for translation initiation (e.g. picornavirus, pestivirus and hepacivirus). Here we review the diverse viral RNA capping mechanisms. Using flavivirus as a model, we summarize how a single methyltransferase catalyses two distinct N-7 and 2′-O methylations of viral RNA cap in a sequential manner. For antiviral development, a structural feature unique to the flavivirus methyltransferase was successfully used to design selective inhibitors that block viral methyltransferase without affecting host methyltransferases. Functionally, capping is essential for prevention of triphosphate-triggered innate immune activation; N-7 methylation is critical for enhancement of viral translation; and 2′-O methylation is important for subversion of innate immune response during viral infection. Flaviviruses defective in 2′-O methyltransferase are replicative, but their viral RNAs lack 2′-O methylation and are recognized and eliminated by the host immune response. Such mutant viruses could be rationally designed as live attenuated vaccines. This concept has recently been proved with Japanese encephalitis virus and dengue virus. The findings obtained with flavivirus should be applicable to other RNA viruses.

UR - http://www.scopus.com/inward/record.url?scp=84897053354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897053354&partnerID=8YFLogxK

U2 - 10.1099/vir.0.062208-0

DO - 10.1099/vir.0.062208-0

M3 - Review article

VL - 95

SP - 763

EP - 778

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

IS - PART 4

ER -